INTRODUCTION
============

*Toxoplasma gondii* is an obligate intracellular parasite of worldwide distribution which infects almost all warm-blooded animals, including humans \[[@B1]\]. It is estimated that nearly one-third of the human population in the world have infection with toxoplasmosis \[[@B1]\]. Because cats are the natural definitive host, they play an important role in the epizootiology of toxoplasmosis. Rodents as generally considered as relevant markers to assess environmental contamination by toxoplasmosis and other pathogens and to estimate the risk of infection for definitive hosts \[[@B2]\]. Behavioral studies comparing infected and uninfected mice have suggested that rodents lose their innate fear of cat odors when chronically infected with *T. gondii* \[[@B3]\], presumably enhancing the transmission of the parasite to its primary host.

In Saudi Arabia, *T. gondii* seroprevalence in rats was 20% in Najran (Southwestern region) in *Meriones rex* \[[@B4]\], and in the Eastern region, 4 out of 5 rodents (mongooses) were found infected \[[@B5]\]. However, in Riyadh, the *T. gondii* seroprevalence was 12.5% (*Mus musculus*) and 41.7% (*Rattus norvegicus*), and the overall rate of infection was 35.6% \[[@B6]\].

The population structure of *T. gondii* includes 3 highly prevalent clonal lineages referred to as types I, II, and III, which differ greatly in virulence in the mouse model \[[@B7]\]. Very little data regarding the *T. gondii* genotypes is published in the Gulf and Saudi Arabia \[[@B8]\]. Defining the *T. gondii* genotypes has important implications for transmission, immunogenicity, and pathogenesis. The present study was conducted to detect *T. gondii* genotypes in rats (*Rattus rattus*) in Riyadh region, Saudi Arabia.

MATERIALS AND METHODS
=====================

Two hundred rats (*Rattus rattus*) were collected from different regions in Riyadh. ELISA IgM assay was conducted for detection of *T. gondii* positive samples followed by PCR amplification of the repetitive *T. gondii* B1gene \[[@B9]\]. Confirmed positive samples were analyzed using a nested-PCR that separately amplifies the 5\'and 3\'ends of *T. gondii* SAG2 locus \[[@B10],[@B11]\]. DNA was purified from blood using Puregene kit by following the instructions of the manufacturer (Gentra Systems, Minneapolis, Minnesota, USA). All procedures for animal experimentation used were approved by the Institutional Animal Ethics Committee, King Saud University, Riyadh, Saudi Arabia (KSU, NO.02/34/IAEC).

Genotype analysis
-----------------

Briefly, PCR was performed using 10× PCR buffer (100 mM Tris-HCl; 500 mM KCl; 15 mM MgCl~2~; 0.01% gelatin) (Sigma Aldrich, St. Louis, Missouri, USA), 1 µM of each primer (Invitrogen-Life Technologies, Eggenstein, Germany), 2 U of Taq DNA polymerase (Invitrogen-Life Technologies) and 150-200 ng of DNA in a total reaction volume of 50 µl. PCR reactions were conducted in a GeneAmp® PCR System 9700 (Applied Biosystems, Foster City, California, USA). The first step of amplification was 10 min of denaturation at 95℃. This step was followed by 40 cycles, with 1 cycle consisting of 60 sec at 95℃, 45 sec at the annealing temperature for each pair of primers, and 60 sec at 72℃. The final cycle was followed by an extension step of 10 min at 72℃.

The 5\'nd of the SAG2 locus was amplified using primers SAG2 F4 (5\'CTACCTCGAACAGGAACAC3\', SAG2 R4 (5\'CATCAACAGTCTTCGTTGC3\' at an annealing temperature of 61.5℃ for 55 sec. A second amplification was performed using 1 µl of the 1:10 diluted PCR products from the first amplification reaction as template for the second round, with similar PCR reaction mixture and conditions except for the primers, which were replaced by the internal set of primers, SAG2F (5\'AAATGTTTCAGGTTGCTGC3\', SAG2 R2 (5\'CAAGAGCGAACTTGAACAC3\'. Amplification of the 3\'nd was performed with primers SAG2 F3 (5\'CTGTTCTCCGAAGTGACTCC3\', SAG2R3 (5\'CAAAGCGTGCATTATCGC3\' at an annealing temperature of 60℃ for 50 sec. For the second amplification, 1 µl of the 1:10 diluted PCR products were used as the template for the second amplification reaction, with internal primers SAG2F2 (5\'TTCTCATGCCTCCGCTTC3\', SAG2R (5\'ACGTTTCACGAAGGCACAC3\'. Similar PCR reaction mixture and conditions of the first amplification were used in the second round and 2% agarose gel was used to analyze the amplified PCR products. The amplified products were purified from primers, nucleotides, polymerases, and salts using, QlAquick PCR purification kit (QIAGEN Inc., Valencia, California, USA) according to the manufacturer\'s instructions.

Restriction digestion
---------------------

Genotype analysis was performed using PCR-RFLP technique. The 5\' end of the purified products of the SAG2 locus were digested using *Sau3A1* endonuclease enzyme, whereas the 3\' end purified products were digested using *Hha1* endonuclease enzyme (Sigma-Aldrish). The products were analyzed using 2% agarose gel (Sigma-Aldrich). *T. gondii* strains RH (type I), LEG 96-1 (type II), and LEG-NJA (type III) were used as controls for lineage types. All the controls were generous gift from Dr. Darde ML, France.

RESULTS
=======

Amplification of SAG2 locus
---------------------------

ELISA IgM assay showed that 27 samples (13.5%) out of 200 were positive. PCR test on *T. gondii* B1 gene showed that, 22 (81.5%) out of the 27 ELISA IgM positive samples, have *T. gondii* DNA (data not shown). The confirmed positive samples were subjected to SAG2 amplification. A nested-PCR method based on the polymorphic SAG2 locus, separately amplifying the 5\'and 3\'ends of the loci was used \[[@B10],[@B11]\]. The amplified products obtained 241 bp ([Fig. 1](#F1){ref-type="fig"}) and 221bp ([Fig. 2](#F2){ref-type="fig"}) fragments for the 5\'and 3\'ends of the loci, respectively.

Restriction digestion
---------------------

The SAG2 PCR products were digested with restriction enzymes, and their type was determined according to the restriction patterns after separation by agarose gel electrophoresis. Three *T. gondii* strains served as lineage controls: RH (type I), LGE 96-1 (type II), and LEG-NJA (type III).

The SAG2 completely characterized samples were 17 out of 22 PCR positive samples (77.3%). When they were subjected to restriction digestion, 13 out of the 17 (76.5%) were characterized as genotype II ([Fig. 3](#F3){ref-type="fig"}) (3\'end fragments were digested by *Hha1* endonuclease enzyme). Four out of 17 (23.5%) were characterized as type III ([Fig. 4](#F4){ref-type="fig"}) (5\'end fragments were digested by *Sau3A1* enzyme.

The rest of the samples (5 samples) were partially characterized, as the 5\' end only could be amplified. Of those fragments, 3 were *Sau3A1* digested and characterized as type III, the other 2 samples were not digested and considered of unknown genotype.

Overall, of the total 22 PCR positive samples, 13 (59.1%) were type II, and 7 (31.8%) were type III, and 2 (9.1%) were of unknown genotype ([Table 1](#T1){ref-type="table"}).

DISCUSSION
==========

In the present study, PCR test on *T. gondii* B1gene showed that 22 (81.5%) out of the 27 ELISA IgM positive samples had *T. gondii* DNA. Only very little data were reported on the *T. gondii* genotypes in the Middle East, and to our knowledge, no reports on the *T. gondii* genotypes studies in rats as well. PCR-RFLP of SAG2 was used to classify *T. gondii* strains. RFLP shows a good sensitivity level (5 parasites/sample) permitting direct typing on clinical samples \[[@B12]\]. RFLP on SAG2 locus has been used for genotyping of *T. gondii* isolates from various animals in Brazil \[[@B13],[@B14]\], other parts of South America \[[@B15]\], and Africa \[[@B16]\].

In the present study, we found that most of the rats were infected with *T. gondii* type II (59.1%; 13 out of 22 PCR positive samples) followed by type III (31.8%; 7 out of 22). To our knowledge, no genotyping studies were conducted in rats in Saudi Arabia. However, there is 1 published study concerning *T. gondii* genotypes in Madinah, Saudi Arabia in humans and farm animals. The authors reported that, the type II isolate was the predominant one (45.1%), and the other genotypes I and III were detected in 20.9% and 21.9% of cases, respectively. They also found that, 12.1% of the samples were of unknown genotypes \[[@B17]\]. In their study, most of the cases were harboring type II, while type I and III were almost equally distributed. The predominance of type II, followed by type III, in the present study agrees, to some extent, to the other from Madinah. However, we found higher percentages of type II (59.1%) and III (31.8%), compared to 45.1% and 21.9%, respectively, in the previous study in Madinah. In UAE and Qatar, type II was found in sand cats in addition to atypical strains \[[@B18]\]. Worldwide, *T. gondii* type II was reported in many food animals \[[@B19]\]. However, strains from infected animals in Egypt \[[@B16]\] and Iran \[[@B20]\] were typed as type II and III, respectively. The high prevalence of type II in animals may underlie the prevalence of *T. gondii* genotypes causing human disease.

None of the samples was harboring *T. gondii* type I in the present study; however, it was detected in Madinah \[[@B17]\] as mentioned previously, the discrepancy could be explained by that different species could harbor different *T. gondii* genotypes, and also the source of infection for the subjects in each study could be different. Other explanation could be that the rat\'s habitats are different from those of humans and domestic animals, and the feeding habits and the route of infection could also be different. Generally, the lack of information on *T. gondii* genotypes in Saudi Arabia specifically and the Middle East in general, makes it difficult to interpret the results of the present study. The absence of the type I strain in countries in the Eastern Mediterranean region in general was reported \[[@B16]\]. We found that 2 (9.1%) samples were of unknown genotype, a finding which agrees to the other from Madinah, in which they found 12.1% were of unknown genotypes \[[@B17]\].

The present study is the first report of *T. gondii* genotyping in wild rats in Saudi Arabia and Gulf region, the results provided preliminary data for further approaches in epidemiology and genotyping of *T. gondii* in these regions. It will be noteworthy to see whether eradication of wild rats in Saudi Arabia will affect the seroprevalence and genotype distribution of *T. gondii*, as rats are abundant in Saudi Arabia. Future studies using analysis of multiple *T. gondii* markers are necessary for new parasite typing identification in Saudi Arabia and the East mediterranean regions.
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![Agarose gel electrophoresis analysis of SAG2 PCR amplification products. Second amplification of the 5\'end of SAG2 locus. Lane 1, positive control. Lanes 2, 3, negative controls. Lanes 4-10, some positive samples (241 bp). Lane 11, 50-bp DNA marker.](kjp-52-257-g001){#F1}

![Agarose gel electrophoresis analysis of SAG2 PCR amplification products. Second amplification of the 3\'end of SAG2 locus. Lane 1, positive control. Lanes 2, 3, negative controls. Lanes 4-13, some positive samples (221 bp). Lane 14, 50-bp DNA marker.](kjp-52-257-g002){#F2}

![Agarose gel electrophoresis analysis of SAG2 PCR amplification products and restriction digests from *T. gondii*-infected samples. Hha1 restriction digestion of 3\'end amplification products of SAG2 locus. Lane 1, type I strain. Lane 2, Type II strain. Lane 3, Type III strain. Lanes 4-6, 8-10, samples of type II strains. Lane 7, non-type II sample. Lane 11, 50-bp DNA marker.](kjp-52-257-g003){#F3}

![Agarose gel electrophoresis analysis of SAG2 PCR amplification products and restriction digests from *T. gondii*-infected samples. *Sau3A1* restriction digestion of the 5\'end amplification products of SAG2 locus. Lane 1, type I strain. Lane 2, type II strain. Lane 3, type III strain. Lanes 4-6, 8-10, samples of non-type III strains. Lane 7, type III sample. Lane 11, 50-bp DNA marker.](kjp-52-257-g004){#F4}
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